Leukocyte and platelet activation in patients with giant cell arteritis and polymyalgia rheumatica: A clue to thromboembolic risks?

Autoimmunity

Volumn 42, Issue 4, 2009, Pages 386-388

  Maugeri, Norma ^a   Baldini, Mattia ^a   Rovere Querini, Patrizia ^a   Maseri, Attilio ^a   Sabbadini, Maria Grazia ^a   Manfredi, Angelo A ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Giant cell arteritis; Nphs; Platelets; Thromboembolism

Indexed keywords

ISOPHANE INSULIN; PADGEM PROTEIN; PREDNISONE; THROMBOPLASTIN;

AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; GIANT CELL ARTERITIS; GRANULOCYTE; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; LEUKOCYTE COUNT; MONOCYTE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RHEUMATIC POLYMYALGIA; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; THROMBOEMBOLISM;

AGED; BLOOD PLATELETS; GIANT CELL ARTERITIS; HUMANS; INFLAMMATION; LEUKOCYTES; MIDDLE AGED; P-SELECTIN; PLATELET ACTIVATION; POLYMYALGIA RHEUMATICA; RISK FACTORS; THROMBOEMBOLISM; THROMBOPLASTIN;

EID: 66149113182     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.1080/08916930902832629     Document Type: Article

References (12)

1. Salvarani C, Cantini F, Hunder GG. Polymyalgia rheumatica and giant cell arteritis. Lancet 2008;372:234-245.
2. Pryshchep O, Ma-Krupa W, Younge BR, Goronzy JJ, Weyand CM. Vessel-specific Toll-like receptor profiles in human medium and large arteries. Circulation 2008;118: 1276-1284.
3. Manfredi AA, Sabbadini MG, Ferri L, Bianchi ME, Rovere- Querini P. Mechanisms of systemic vasculitis. Drug Discov Today Dis Mech 2004;1:297-302.
4. Ruegg S, Engelter S, Jeanneret C, Hetzel A, Probst A, Steck AJ, et al. Bilateral vertebral artery occlusion resulting from giant cell arteritis: Report of 3 cases and review of the literature. Medicine 2003;82:1-12.
5. Salvarani C, Casali B, Farnetti E, Pipitone N, Formisano D, Nicoli D, et al. PlA1/A2 polymorphism of the platelet glycoprotein receptor IIIA and risk of cranial ischemic complications in giant cell arteritis. Arthritis Rheum 2007; 56:3502-3508.
6. Nesher G, Berkun Y, Mates M, Baras M, Rubinow A, Sonnenblick M. Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis. Arthritis Rheum 2004;50:1332-1337. (Pubitemid 38480844)
7. Lee MS, Smith SD, Galor A, Hoffman GS. Antiplatelet and anticoagulant therapy in patients with giant cell arteritis. Arthritis Rheum 2006;54:3306-3309.
8. FoellD, Hernandez-Rodriguez J, Sanchez M, Vogl T, Cid MC, Roth J. Early recruitment of phagocytes contributes to the vascular inflammation of giant cell arteritis. J Pathol 2004;204: 311-316.
9. Chatelain D, Duhaut P, Schmidt J, Loire R, Bosshard S, Guernou M, et al. Pathological features of temporal arteries in patients with giant cell arteritis presenting with permanent visual loss. Annals Rheum Dis 2009;68:84-88.
10. Furie B, Furie BC. Mechanisms of thrombus formation. New Engl J Med 2008;359:938-949.
11. MaugeriN,GiordanoG, PetrilliMP, FraticelliV, deGaetanoG, Cerletti C, et al. Inhibition of tissue factor expression by hydroxyurea in polymorphonuclear leukocytes from patients with myeloproliferative disorders: A new effect for an old drug? J Thromb Haemost 2006;4:2593-2598.
12. NesherG, BerkunY,MatesM, BarasM, NesherR, Rubinow A, et al. Risk factors for cranial ischemic complications in giant cell arteritis. Medicine 2004;83:114-122.